GLYC - GLYCOMIMETICS INC

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 1.64

Open

$ 1.69

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.63 - $ 1.76

52 Week Range

$ 1.11 - $ 3.53

Volume

1,015,401

Average Volume

Market Cap

103.88M

Beta (5Y Monthly)

$ 1.70

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-27-2024	12-31-2023	10-K
2	11-03-2023	09-30-2023	10-Q
3	08-02-2023	06-30-2023	10-Q
4	05-03-2023	03-31-2023	10-Q
5	03-29-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-03-2022	06-30-2022	10-Q
8	04-28-2022	03-31-2022	10-Q
9	03-03-2022	12-31-2021	10-K
10	11-02-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-03-2021	03-31-2021	10-Q
13	03-02-2021	12-31-2020	10-K
14	11-06-2020	09-30-2020	10-Q
15	07-31-2020	06-30-2020	10-Q
16	05-01-2020	03-31-2020	10-Q
17	02-28-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-01-2019	06-30-2019	10-Q
20	05-02-2019	03-31-2019	10-Q
21	03-06-2019	12-31-2018	10-K
22	11-02-2018	09-30-2018	10-Q
23	08-09-2018	06-30-2018	10-Q
24	05-03-2018	03-31-2018	10-Q
25	03-06-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-03-2017	06-30-2017	10-Q
28	05-08-2017	03-31-2017	10-Q
29	03-01-2017	12-31-2016	10-K
30	11-04-2016	09-30-2016	10-Q
31	08-04-2016	06-30-2016	10-Q
32	05-04-2016	03-31-2016	10-Q
33	02-29-2016	12-31-2015	10-K
34	11-12-2015	09-30-2015	10-Q
35	08-06-2015	06-30-2015	10-Q
36	05-05-2015	03-31-2015	10-Q
37	03-16-2015	12-31-2014	10-K
38	10-31-2014	09-30-2014	10-Q
39	07-31-2014	06-30-2014	10-Q
40	05-09-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
03/27/2024 20:31:13

HC Wainwright & Co. Maintains Buy on Glyco...
03/27/2024 17:42:08

HC Wainwright & Co. analyst Edward White maintains GlycoMimetics (NASDAQ:GLYC) with a Buy and maintains $8 price target.

GlycoMimetics Q4 EPS $(0.14) Beats $(0.15)...
03/27/2024 11:02:17

GlycoMimetics (NASDAQ:GLYC) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15)...

Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

Earnings Outlook For GlycoMimetics
03/26/2024 16:00:50

12 Health Care Stocks Moving In Wednesday'...
01/24/2024 21:31:07

Glycomimetics Announced Initial Safety, To...
01/04/2024 12:16:51

why-trinity-place-holdings-shares-are-trading-higher-by-80-here-are-20-stocks-moving-premarket

Why Trinity Place Holdings Shares Are Trad...
01/03/2024 12:59:21

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mor...

GlycoMimetics Entered Into Project Agreeme...
01/02/2024 21:36:03

-SEC 8K Filing

Capital One Initiates Coverage On GlycoMim...
12/22/2023 12:09:50

Capital One analyst Zegbeh Jallah initiates coverage on GlycoMimetics (NASDAQ:GLYC) with a Overweight rating and announces P...

Earnings Scheduled For November 3, 2023
11/03/2023 11:12:01

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per ...

GlycoMimetics Q3 EPS $(0.14), Inline; Cash...
11/03/2023 11:02:56

GlycoMimetics (NASDAQ:GLYC) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a ...

Earnings Outlook For GlycoMimetics
11/02/2023 18:02:08

Glycomimetics Has Started Dosing The First...
09/06/2023 11:13:27

HC Wainwright & Co. Reiterates Buy on Glyc...
08/03/2023 10:15:58

HC Wainwright & Co. analyst Edward White reiterates GlycoMimetics (NASDAQ:GLYC) with a Buy and maintains $8 price target.

Earnings Scheduled For August 2, 2023
08/02/2023 12:45:48

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earn...

GlycoMimetics Q2 EPS $(0.13) Beats $(0.18)...
08/02/2023 11:13:55

GlycoMimetics (NASDAQ:GLYC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18)...

GlycoMimetics Announces Its Addition To Th...
06/26/2023 12:12:59

GlycoMimetics, Inc. (NASDAQ:GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based th...

HC Wainwright & Co. Reiterates Buy on Glyc...
06/15/2023 16:14:13

HC Wainwright & Co. analyst Edward White reiterates GlycoMimetics (NASDAQ:GLYC) with a Buy and maintains $8 price target.